MN-25
MN-25 (compound 4a) is an orally active indolpyridone that serves as a novel cannabinoid ligand. MN-25 has Ki of 245 nM and 11 nM for CB1 and CB2. MN-25 has CB2 agonist activity and inhibits TNF-R release in human peripheral blood mononuclear cells in vitro with an IC50 of 33 μM. MN-25 shows efficacy in a mouse acute inflammation model at oral doses up to 50 mg/kg>[1].
Product Specifications
CAS Number
501926-82-5
UNSPSC
12352005
Target
Cannabinoid Receptor; TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mn-25.html
Smiles
C[C@]1(C[C@](CC1)([H])C2(C)C)[C@@H]2NC(C3=CN(C4=C(OC)C=CC=C43)CCN5CCOCC5)=O
Molecular Formula
C26H37N3O3
Molecular Weight
439.59
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
DLX3 (NM_005220) Human Tagged ORF Clone Lentiviral Particle
Influenza A H1N1 (A/California/04/2009) Hemagglutinin/HA Antibody, Rabbit PAb, Antigen Affinity Purified
Influenza A H1N1 (A/California/04/2009) Hemagglutinin/HA Antibody, Rabbit PAb, Antigen Affinity Purified
Influenza A H1N1 (A/California/04/2009) Hemagglutinin/HA Antibody, Rabbit PAb, Antigen Affinity Purified